Daily News Podcast

SGLT2s for heart failure first, diabetes second

Publish date: February 11, 2019

 

For patients with systemic heart failure but without diabetes, oral SGLT2s are the focus of multiple ongoing phase 3 clinical trials. Also today, influenza activity hits a seasonal high, the U.S. Supreme Court halts a Louisiana abortion law from taking effect, and cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Socioeconomic status, race found to impact CPAP compliance
MDedge Family Medicine
Adolescence does not rule out bullous pemphigoid
MDedge Family Medicine
What is your diagnosis?
MDedge Family Medicine
Supreme Court halts Louisiana abortion law from taking effect
MDedge Family Medicine
In search of an ear
MDedge Family Medicine
Flu activity hits seasonal high
MDedge Family Medicine
Most U.S. tPA-eligible stroke patients now get treated within an hour
MDedge Family Medicine
LGBTQ youth struggle in foster or unstable housing situations
MDedge Family Medicine
High prevalence of sleep problems in children with autism spectrum disorder
MDedge Family Medicine
Hidradenitis suppurativa linked to increased lymphoma risk
MDedge Family Medicine